Rigel Pharmaceuticals (RIGL) Debt to Equity (2019 - 2026)
Rigel Pharmaceuticals' quarterly Debt to Equity came in at $0.19 in Q1 2026, down 94.19% year-on-year from $3.22 in Q1 2025, and up 39.88% quarter-over-quarter from $0.13 in Q4 2025.
Rigel Pharmaceuticals has reported Debt to Equity for 8 years, with the latest figure at $0.19 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 94.19% year-over-year to $0.19; the trailing twelve-month figure through Mar 2026 stood at $0.19 (down 94.19% YoY), and the FY2025 full-year result was $0.13, down 99.26% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.19, up from $0.13 in the prior quarter.
- The five-year high for Debt to Equity was $18.15 in Q4 2024, with the low at -$8.11 in Q2 2022.
- Average Debt to Equity over 5 years is -$0.13, with a median of -$1.88 recorded in 2024.
- Peak annual rise in Debt to Equity reached 1632.37% in 2022, while the deepest fall reached 2882.69% in 2022.
- Tracing RIGL's Debt to Equity over 5 years: stood at -$2.9 in 2022, then climbed by 28.18% to -$2.08 in 2023, then soared by 972.31% to $18.15 in 2024, then tumbled by 99.26% to $0.13 in 2025, then soared by 39.88% to $0.19 in 2026.
- The last three Debt to Equity figures came in at $0.19 (Q1 2026), $0.13 (Q4 2025), and $0.51 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.19 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 3.22 |
| Dec 31, 2024 | 18.15 |
| Sep 30, 2024 | -4.08 |
| Jun 30, 2024 | -2.00 |
| Mar 31, 2024 | -1.88 |
| Dec 31, 2023 | -2.08 |
| Sep 30, 2023 | -1.87 |
| Jun 30, 2023 | -2.12 |
| Mar 31, 2023 | -2.45 |
| Dec 31, 2022 | -2.90 |
| Sep 30, 2022 | -1.99 |
| Jun 30, 2022 | -8.11 |
| Mar 31, 2022 | 4.39 |
| Dec 31, 2021 | 0.66 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | 0.29 |
| Mar 31, 2021 | 0.25 |
| Dec 31, 2020 | 0.58 |
| Sep 30, 2020 | 0.39 |
| Jun 30, 2020 | 0.31 |
| Mar 31, 2020 | 0.13 |
| Dec 31, 2019 | 0.18 |
| Sep 30, 2019 | 0.14 |